Vector and method for enhancing transcriptional activity of adjacent promoters
By adjusting the length of adjacent promoter intervals in baculovirus vectors, the transcriptional interference problem is solved, the yield and protein expression level of recombinant adeno-associated viruses are improved, and more efficient expression of multiple proteins is achieved.
Patent Information
- Application Number
- PCT/CN2023/095761
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-11-28
AI Technical Summary
The existing baculovirus vectors have transcriptional interference when expressing the two proteins, resulting in low yield of recombinant AAV particles, which cannot effectively avoid transcriptional interference between adjacent promoters, affecting protein yield.
Insert DNA sequences between two adjacent reverse baculovirus late or extremely late promoters, so that the transcription start sites of the two promoters are spaced by more than 133 nucleotides and less than 161 nucleotides, ensuring that the promoter is Independent transcription between.
By optimizing the promoter interval length, the transcriptional activity of adjacent promoters is improved, the yield and protein expression level of recombinant adeno-associated viruses are significantly improved, transcriptional interference is avoided, and more efficient expression of multiple proteins is achieved.
Smart Images

Figure CN2023095761_28112024_PF_FP_ABST
Abstract
Description
A vector and method for enhancing the transcriptional activity of adjacent promoters Technical Field
[0001] The present invention relates to the field of biotechnology or genetic engineering. Specifically, the present invention relates to the field of gene expression. More specifically, the present invention relates to a vector and method for eliminating transcriptional interference between two reversely arranged genes. Background Art
[0002] Transcriptional interference refers to the phenomenon of reduced gene expression caused by transcription from adjacent upstream and downstream promoters. This phenomenon was discovered early on in mammals, yeast, and prokaryotes (EMBO J. 1993.12:2539-2548; Proc. Natl. Acad. Sci. USA 2000.97:8415-8420.6; Nature 1986.322:562-565). Two promoters that experience transcriptional interference can be arranged in three different configurations: tandem, convergent, and divergent. In a divergent arrangement, two adjacent expression cassettes are placed back-to-back, with transcription from the two promoters in opposite directions, and the two transcription events proceed from the center to the ends. In this situation, if the promoter sequences overlap or intersect, steric hindrances will occur when the two RNA polymerases recognize the promoters separately, resulting in reduced transcription levels from both expression cassettes and ultimately affecting protein production. A strategy to avoid transcriptional interference is to insert a sufficiently long spacer sequence between the two promoters to make the transcription of the two promoters completely independent.
[0003] The baculovirus-insect cell expression system is a protein expression technology that uses baculovirus as a vector to express foreign proteins in insect cells. Because insect cells have a protein post-translational modification system similar to that of mammalian cells and their cultivation costs are lower than those of mammalian cells, they are a preferred system for expressing biologically active proteins. Another advantage of this system is the large capacity of baculovirus vectors, making them particularly suitable for the simultaneous expression of multiple proteins. Currently, the widely used baculovirus vector plasmid for the simultaneous expression of two proteins is ThermoFisher's pFastBac Dual. This vector contains two back-to-back expression cassettes, controlled by the p10 promoter and the polyhedral pH promoter, respectively. The p10 and pH promoters are baculovirus very late promoters that require recognition by the baculovirus-encoded RNA polymerase. The spatial size of the baculovirus-encoded RNA polymerase is currently unclear. In the pFastBacDual plasmid, the transcription start sites of the two promoters are separated by 105 nucleotides, and it is unclear whether this spacing prevents transcriptional interference.
[0004] When producing recombinant adeno-associated virus (AAV) using baculovirus, the inventors discovered that when a single recombinant baculovirus expressed the Cap and Rep proteins back-to-back (with the same spacing between the transcription start sites of the two promoters as in the prior art pFastBacDual plasmid), the yield of recombinant AAV particles was significantly lower than when two recombinant baculoviruses expressing the Cap and Rep proteins were co-infected in insect cells. This result suggests that the prior art suffers from transcriptional interference.
[0005] Using one recombinant virus to express two proteins is superior to using two recombinant viruses to co-infect cells in terms of production process. First, the ratio of the two proteins in a single virus is stable, while the ratio between the two viruses needs to be adjusted. Second, the total amount of virus that infects the cells is fixed, so the dose of the exogenous gene in the two viruses is lower than that in a single virus. However, there is transcriptional interference when expressing two proteins with a single virus, resulting in the process advantages being insufficient to compensate for the disadvantages caused by reduced yield. If transcriptional interference can be avoided or transcription of adjacent promoters can be further promoted, the baculovirus expression vector can be made more suitable for expressing multiple proteins at the same time.
[0006] Summary of the Invention
[0007] The purpose of the present invention is to provide a vector and method for enhancing the transcriptional activity of an adjacent promoter, aiming to solve the problems mentioned in the background art.
[0008] The first object of the present invention is to provide a DNA sequence comprising two adjacent promoters with opposite transcription, wherein the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides, and the promoter is a baculovirus late or very late promoter.
[0009] The present invention is achieved by inserting a DNA sequence between two adjacent, oppositely oriented baculovirus late or very late promoters, such that the transcription start sites of the two promoters are separated by a distance greater than 133 nucleotides and less than 161 nucleotides. This DNA sequence comprising the promoter and spacer sequence can be a linear DNA segment, contained within a plasmid, or contained within the baculovirus genome. A second object of the present invention is to provide a recombinant baculovirus for simultaneously expressing two exogenous proteins. This is achieved by inserting two adjacent exogenous protein expression cassettes with opposite transcription directions into the baculovirus genome, wherein the promoters of the two expression cassettes are baculovirus late or very late promoters, and the transcription start sites of the two promoters are separated by a distance greater than 133 nucleotides and less than 161 nucleotides.
[0010] Furthermore, the present invention is applicable to promoters that contain TAAG late elements, including but not limited to p10, polh, p6.9, vp39, and gp64 promoters.
[0011] Preferably, the baculovirus late or very late promoter is the polh promoter, the p10 promoter or the p6.9 promoter.
[0012] Furthermore, the proteins encoded by the two expression cassettes are the Cap protein and the Rep protein of adeno-associated virus, respectively.
[0013] The third object of the present invention is to provide a method for enhancing the transcriptional activity of an adjacent promoter, in order to solve the problems mentioned in the background art.
[0014] The method provided by the present invention is to insert a DNA sequence between two adjacent reverse baculovirus late or very late promoters so that the interval between the transcription start sites of the two promoters is greater than 133 nucleotides and less than 161 nucleotides.
[0015] A fourth object of the present invention is to provide a method for producing a recombinant adeno-associated virus, wherein the expression vector is a baculovirus, the Cap protein and Rep protein expression cassettes are adjacent and in opposite directions, the promoter of the expression cassette is a baculovirus late or very late promoter, and the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides, comprising the following steps:
[0016] (1) Construct two expression cassettes for the simultaneous expression of adeno-associated virus Cap and Rep proteins: "Rep protein <-p10 promoter-spacer sequence-polh promoter->Cap protein";
[0017] (2) The two expression cassette sequences were seamlessly cloned into the plasmid pQB3 (Shaanxi Bacmid Biotechnology Co., Ltd.) to obtain the pQB3Rep-147-Cap plasmid;
[0018] (3) The transfer vector plasmid and linearized Bacmid (qBac-IIIG, Shaanxi Bacmid Biotechnology Co., Ltd.) were co-transfected into Sf9 insect cells, and the supernatant was collected as the P0 virus;
[0019] (4) Infect Sf9 cells with P0 virus to obtain P1 virus;
[0020] (5) The above-mentioned P1 virus and the recombinant virus carrying the adeno-associated virus ITR sequence were co-infected into Sf9 cells at an MOI of 3, and the cells were cultured and collected.
[0021] The method provided by the present invention uses a baculovirus as an expression vector, and clones two expression cassettes controlled by a baculovirus late or very late promoter into the baculovirus expression vector, wherein the expression cassettes are adjacent and in opposite directions, and the proteins encoded by the two expression cassettes are respectively the Cap protein and the Rep protein of the adeno-associated virus, and the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides.
[0022] Beneficial effects of the present invention: If the spacing is too short, there will be steric hindrance between the two polymerases that recognize the two promoters, and the promoter recognized first by the polymerase will affect the recognition of the next promoter. If the spacing is very long, the two promoters can be considered to be completely independent, there is no transcription interference between them, and the transcription levels of the two promoters are normal. When the spacing is within a certain suitable interval, preferably the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides, the DNA double helix of the promoter recognized first will melt after the polymerase enters; at this time, the other promoter can also be recognized by the polymerase because there is no steric hindrance, and the nearby melted DNA can promote the melting of the sequence recognized by the next polymerase, so that the first polymerase apparently promotes the entry of the second polymerase. In this interval, the two promoters not only do not interfere with each other, but also have a promoting effect on each other. In particular, the transcription level with an interval of 147 nucleotides is much higher than that of independent transcription. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] FIG1 shows a model of the present invention in which suitable spacing between promoters can promote transcription.
[0024] Figure 2 uses the Rep gene as an example to examine the effects of different spacer lengths on the transcription level of the p10 promoter.
[0025] Figure 3 uses the Cap gene as an example to examine the effects of different spacer lengths on the transcription level of the polh promoter.
[0026] FIG4 takes recombinant AAV as an example to examine the effect of different spacer lengths on the yield of the final recombinant adeno-associated virus product of two co-expressed genes. DETAILED DESCRIPTION
[0027] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0028] Based on the sequence of the prior art pFastBac Dual, two expression cassettes were constructed to simultaneously express the adeno-associated virus Cap and Rep proteins: "Rep protein <- p10 promoter-spacer sequence-polh promoter -> Cap protein". The sequence between the two promoter TAAG elements is as follows:
[0029] The initial CTTA is the reverse complement of the TAAG element of the p10 promoter, and the final TAAG is the polh promoter element. The lowercase letters in the middle are spacer sequences, which only indicate the spacing and are not related to the specific sequence. The transcription start site of the baculovirus late / very late promoter is located at the first adenine nucleotide of the TAAG element, so the spacing between the two promoter transcription start sites in the above sequence is 105 nucleotides.
[0030] The two expression cassette sequences were cloned into the plasmid pQB3 (Shaanxi Bacmid Biotechnology Co., Ltd.) by seamless cloning to obtain the pQB3Rep-105-Cap plasmid.
[0031] A pair of reverse primers were designed near the spacer sequence. Using the pQB3Rep-105-Cap plasmid as a template, the entire plasmid was amplified and then seamlessly cloned. This allows the length of the spacer sequence to be varied by adjusting the primer sequence. The plasmids with different spacer sequences obtained are as follows:
[0032] pQB3Rep-98-Cap spacer sequence gctagcatattaatagat.
[0033] pQB3Rep-119-Cap spacer sequence tcactcccaatagctgtcatggacgccatattaatagat
[0034] pQB3Rep-133-Cap spacer sequence gctagccgttactgtcactcccaatagctgtcatggacgccatattaatagat
[0035] pQB3Rep-147-Cap spacer sequence ttgatgactacgcagctagccgttactgtcactcccaatagctgtcatggacgccatattaatagat
[0036] pQB3Rep-161-Cap spacer sequencettgatgactacgcaacataaccggatacgctagccgttatactgtcactcccaatagctgtcatggacgccatattaatagat
[0037] pQB3Rep-175-Cap spacer sequencettgatgactacgcatccgaagtgtctaaacataaccggatacgctagccgttatactgtcactcccaatagctgtcatggacgccatattaatagat
[0038] The above seven transfer vector plasmids were co-transfected with linearized Bacmid (qBac-IIIG, Shaanxi Bacmid Biotechnology Co., Ltd.) into Sf9 insect cells. After 5 days of culture, the supernatant was collected as the P0 virus. 20 μl of P0 virus per 35 mm culture dish was used to infect Sf9 cells to obtain the P1 virus.
[0039] Sf9 cells were co-infected with the aforementioned P1 virus and a recombinant virus containing an AAV ITR sequence at an MOI of 3. Cells were harvested on day 5, and the titer of the recombinant AAV (copy number of the reporter gene mCherry sequence located between the ITR sequences) was determined by real-time quantitative PCR. RNA was extracted from the cell lysate, reverse transcribed, and then analyzed by real-time quantitative PCR for the transcription levels of Rep and Cap. gp41 was used as an internal control.
[0040] The detection primers are as follows:
[0041] qpcr-mCh-F:AGTTCATGTACGGTCCAAG
[0042] qpcr-mCh-R:TTGTAGATGAACTCGCCGTC
[0043] qpcr-Rep-F:GCTTCCTCCGAGAATGGCTT
[0044] qpcr-Rep-R:TACGGGTGCGTAAACTGGAC
[0045] qpcr-Cap-F:GCCACCAAGTACCACCTGAA
[0046] qpcr-Cap-R: CACCGGACTGAGGGAAGAAC
[0047] qpcr-gp41-F:CGTAGTGGTAGTAATCGCCGC
[0048] qpcr-gp41-R:AGTCGAGTCGCGTCGCTTT
[0049] The application effects of the present invention are further described below in conjunction with the embodiments.
[0050] 1. The transcription levels of Rep and Cap proteins change with the length of the spacer sequence.
[0051] As can be seen from FIG2 , as the length of the spacer sequence changes, the transcription level of the Rep gene changes, and within the range of 98-175 nucleotides in length, a peak at 147 nucleotides appears.
[0052] As can be seen from FIG3 , as the length of the spacer sequence changes, the transcription level of the Cap gene changes. Within the range of 98-175 nucleotides, a peak at 147 nucleotides appears, which is significantly higher than that of other spacers.
[0053] 2. The yield of recombinant adeno-associated virus changes with the length of the spacer sequence.
[0054] As can be seen from FIG4 , the yield of recombinant adeno-associated virus changes with the change of the length of the spacer sequence. Within the range of 98-175 nucleotides, a peak at 147 nucleotides appears, which is significantly higher than that of other spacers.
[0055] Compared to the existing technology (spacer 105), when the spacer is 133 nucleotides or greater, the transcription levels of Rep and Cap proteins and the yield of recombinant adeno-associated virus are improved. This suggests that: 1. The existing technology may interfere with transcription; 2. The traditional strategy of adding spacer sequences can indeed avoid transcription interference.
[0056] However, the core effect of the present invention is not to avoid transcription interference by adding a spacer sequence, but to optimize an interval (near 147 nucleotides, greater than 133 nucleotides and less than 161 nucleotides) in which the two promoters not only do not interfere with each other, but instead promote each other. This promotion is manifested in that the transcription levels of the two expression cassettes increase near the interval of 147 nucleotides, with values higher than those of 161 and 175 nucleotides. It is generally believed that when the interval between the two promoters is long enough, transcription can be considered independent. In this example, the interval of 175 nucleotides can be considered independent transcription. In other words, the transcription level of the interval of 147 nucleotides is higher than that of independent transcription.
[0057] By replacing the Rep and Cap gene coding regions of pQB3Rep-147-Cap with a multiple cloning site, a universal vector plasmid capable of simultaneously and efficiently expressing two proteins can be obtained.
[0058] By using, but not limited to, overlapping PCR technology, the coding region of the exogenous gene is connected to the sequence between the multiple cloning sites of the universal vector plasmid, thereby obtaining a DNA sequence containing two adjacent promoters with opposite transcription, and the promoters can promote each other.
[0059] The above description is only an embodiment of the present invention and is not intended to limit the present invention. The spacer region suitable for transcription promotion is an interval, and the range of 13 nucleotides upstream and downstream of the preferred point detected in this embodiment should be regarded as the protection scope of the present invention. The promoters applicable to the present invention are all promoters containing TAAG late elements, including but not limited to p10, polh, p6.9, vp39, and gp64 promoters. Its sequence is 5'CTTAN(134-160)TAAG3'. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A DNA sequence, characterized in that: The DNA sequence comprises two adjacent promoters with opposite transcription, the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides, and the promoter is a late or very late promoter of baculovirus.
2. The DNA sequence according to claim 1, characterized in that: The promoters are all promoters containing TAAG late elements 3. The DNA sequence according to claim 2, characterized in that: The promoter is baculovirus p10, polh, p6.9, vp39 or gp64 promoter.
4. A DNA sequence according to any one of claims 1 to 3, characterized in that: The DNA sequence is a linear DNA contained in a plasmid or contained in a baculovirus genome.
5. A recombinant baculovirus, characterized in that: The recombinant baculovirus comprises two adjacent foreign protein expression cassettes with opposite transcription directions, the transcription start sites of the two expression cassette promoters are separated by more than 133 nucleotides and less than 161 nucleotides, and the promoter is a baculovirus late or very late promoter.
6. The recombinant baculovirus according to claim 5, characterized in that The promoter is baculovirus polh promoter, p10 promoter or p6.9 promoter.
7. The recombinant baculovirus according to claim 5 or 6, characterized in that The protein expression cassette encodes the Cap protein and the Rep protein of the adeno-associated virus.
8. A method for enhancing transcription of two adjacent reverse promoters in a recombinant baculovirus, characterized in that: A DNA sequence is inserted between the two promoters so that the interval between the transcription start sites of the two promoters is greater than 133 nucleotides and less than 161 nucleotides. The promoter is a baculovirus late and / or very late promoter.
9. The method according to claim 8, characterized in that The promoter is baculovirus polh promoter, p10 promoter or p6.9 promoter.
10. A method for producing a recombinant adeno-associated virus, characterized in that: The expression vector is a baculovirus, the Cap protein and Rep protein expression cassettes are adjacent and in opposite directions, the promoter of the expression cassette is a baculovirus late or very late promoter, and the transcription start sites of the two promoters are separated by more than 133 nucleotides and less than 161 nucleotides.
Citation Information
Patent Citations
Multiple RNA polymerase III promoter expression constructs
CN101189343A
Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
CN107119073A
Method for improving production of adeno-associated virus by baculovirus system and application
CN115851837A
Method to reduce transcriptional interference between tandem genes
US20020155540A1
